期刊文献+

心房颤动住院患者的临床特点及抗凝治疗 被引量:4

Retrospective Study on the Clinical Characteristics and Anticoagulation Therapy of Inpatients with Atrial Fibrillation
下载PDF
导出
摘要 【目的】了解现阶段心房颤动(房颤)患者的流行病学变化、临床特征及抗凝治疗情况。【方法】对本院出院诊断为房颤有心脏超声资料的921例患者进行分析。【结果】①住院房颤患者中瓣膜性房颤占房颤病人总数的38.8%;非瓣膜性房颤占61.2%,病因以高血压病、冠心病、孤立性房颤、扩张型心肌病为主。②大于70岁房颤占30.3%,年龄越大房颤发生率越高。③左心房超声记录中左房增大(>40mm)占71.9%;约21.4%有左室射血分数降低;阵发性房颤369例(40.1%),持续性房颤552例(59.9%),持续性房颤患者左心房明显大于阵发性房颤患者(P<0.01)。④应用华发林抗凝治疗76例,仅占8.3%。【结论】非瓣膜性房颤已成为现阶段房颤的主要病因,年龄和高血压是房颤最常见的相关因素。应积极应用华发林抗凝治疗。 [Objective]To explore the epidemiological changes, clinical characteristics and the strategies of anticoagulation therapy for inpatients with atrial fibrillation (AF). [Methods]Nine hundred and twenty one inpatients with AF were involved in the present study. [Results](1)38.8 % patients suffered from valvar AF and 61.2% patients with non-valve AF, most of whom got from hypertension, coronary artery disease, and idiopathic atrial fibrillation and dilated cardiomyopathy. (2)30.3 % patients were senile (aged above 70 years old), and older patients suffered AF more easily. (3)All patients took the ultrasonic record on left atrium, 71.9 % of them had an enlarged left atrium, and 21.4% of them had a decreased left ventricle ejection fraction (LVEF). There was a significant difference in the enlarged left atrium between the two groups ( P 〈0.01). (4)All inpatients accepted aspirin therapy and 8.3 % of them accepted warfarin therapy. [Conclusion]Senium and hypertension are the most common causes of atrial fibrillation, so it is very important to utilize warfarin.
出处 《医学临床研究》 CAS 2008年第3期437-439,共3页 Journal of Clinical Research
关键词 抗凝药/治疗应用 心房颤动/药物疗法 心房颤动/病理生理学 血栓溶解疗法 住院病人 anticoagulants/TU atrial fibrillation/DT atrial fibrillation/PP thrombolytic thera-py inpatients
  • 相关文献

参考文献7

  • 1戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3Fuster V, Ryden LE, Asinger RW, et al . ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. JACC ,2001,22:1852-1923.
  • 4Hirsh J, Fuster V. Guide to antieoagulant therapy. Part 2 : Oral anticoagulants [ J ]. American Heart Association Circulation, 1994,89 : 1469-1480.
  • 5Hart RG,Benavent O,MeBride R, et al. Antithrombotie therapy to prevent stroke in patients with atrial fibrillation : a meta-analysis[J]. Ann Intern Med , 1999,131 : 492-501.
  • 6Pappone C , Augello G, Santinelli V. Atrial fibrillation ablation[J]. Ital Heart J , 2005 ,6:190-199.
  • 7Mukherjee R, Herron AR. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventrieular myoeardium in patients with atrial fibrillation[J]. Am J Cardiol , 2006,97(4) : 532- 537.

二级参考文献1

共引文献1642

同被引文献54

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部